Retatrutide Trial Results: Percent Weight Loss vs Pounds
Percentage weight change relates the change to baseline weight. Pounds and kilograms describe absolute change. A given percentage represents different amounts at different starting weights.
Percentage weight change relates the change to baseline weight. Pounds and kilograms describe absolute change. A given percentage represents different amounts at different starting weights.
A placebo group helps researchers estimate how an intervention performed relative to the conditions of that trial. Changes can occur in both arms during follow-up.
A weight-change curve shows estimated group outcomes across scheduled visits. The horizontal axis usually shows time, and the vertical axis shows mean change from baseline.
A study average combines a range of outcomes. Participants can reach different weight-loss thresholds, experience different adverse events, or discontinue assigned treatment.
Retatrutide’s TRIUMPH-1 and semaglutide’s STEP 1 both used placebo comparators. They enrolled different study populations and assessed weight change at different times.
In SURMOUNT-5, adults with obesity without diabetes were randomized to tirzepatide or semaglutide. At 72 weeks the estimated mean weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide.
TRIUMPH-1, SURMOUNT-1 and STEP 1 are placebo-controlled studies of different interventions. Their published figures belong to their own populations, regimens, follow-up and analyses.
TRIUMPH-5 is registered as NCT06662383. Its direct comparison tests both treatments in adults with obesity using a shared trial protocol.
A 48-week study and an 80-week study measure outcomes over different periods. Enrollment, baseline characteristics, comparator conditions and analytical methods can also differ.
TRIUMPH-4 enrolled participants with obesity or overweight and knee osteoarthritis. The design assessed body weight and knee symptoms within the same research program.